Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2022 Publisher: Aspire Pharma Ltd, Unit 4 Rotherbrook Court, Bedford Road, Petersfield, Hampshire, GU32 3QG, United Kingdom
Zedbac 500 mg powder for solution for infusion.
Pharmaceutical Form |
---|
Powder for solution for infusion. Free white powder. |
Each vial contains 500 mg of azithromycin (equivalent to 524.1 mg of azithromycin dihydrate), which after reconstitution results in a 100 mg/ml azithromycin solution. The concentrate should be further diluted to 1 mg/ml or 2 mg/ml.
Excipient(s) with known effect: This medicinal product contains 114 mg (4.96 mmol) sodium per vial.
For the full list of excipients, see Section 6.1.
Active Ingredient | Description | |
---|---|---|
Azithromycin |
Azithromycin is a macrolide antibiotic belonging to the azalide group. The molecule is constructed by adding a nitrogen atom to the lactone ring of erythromycin A. The mechanism of action of azithromycin is based upon the suppression of bacterial protein synthesis by means of binding to the ribosomal 50S sub-unit and inhibition of peptide translocation. |
List of Excipients |
---|
Anhydrous citric acid |
Azithromycin is packed in 12 ml glass (type I) vials with bromobutyl rubber stopper and sealed with aluminium/plastic flip-off cap.
Pack sizes of 1 vial with powder for solution for infusion.
Aspire Pharma Ltd, Unit 4 Rotherbrook Court, Bedford Road, Petersfield, Hampshire, GU32 3QG, United Kingdom
PL 35533/0026
19/09/2012
Drug | Countries | |
---|---|---|
ZEDBAC | Estonia, Ireland, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.